Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2002-12-13
pubmed:abstractText
To assess the antidepressant efficacy and tolerability of adjunctive pramipexole, a D2-D3 dopamine agonist, in patients with drug-resistant depression.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1398-5647
pubmed:author
pubmed:issnType
Print
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
307-14
pubmed:dateRevised
2007-3-22
pubmed:meshHeading
pubmed-meshheading:12479663-Adult, pubmed-meshheading:12479663-Aged, pubmed-meshheading:12479663-Antidepressive Agents, Tricyclic, pubmed-meshheading:12479663-Benzothiazoles, pubmed-meshheading:12479663-Combined Modality Therapy, pubmed-meshheading:12479663-Depressive Disorder, Major, pubmed-meshheading:12479663-Dopamine Agonists, pubmed-meshheading:12479663-Drug Administration Schedule, pubmed-meshheading:12479663-Drug Resistance, Multiple, pubmed-meshheading:12479663-Drug Therapy, Combination, pubmed-meshheading:12479663-Electroconvulsive Therapy, pubmed-meshheading:12479663-Female, pubmed-meshheading:12479663-Humans, pubmed-meshheading:12479663-Male, pubmed-meshheading:12479663-Middle Aged, pubmed-meshheading:12479663-Prospective Studies, pubmed-meshheading:12479663-Serotonin Uptake Inhibitors, pubmed-meshheading:12479663-Thiazoles
pubmed:year
2002
pubmed:articleTitle
Pramipexole in treatment-resistant depression: a 16-week naturalistic study.
pubmed:affiliation
Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Italy. paolo.cassano@psico.med.unipi.it
pubmed:publicationType
Journal Article, Clinical Trial